Rohith Motappa

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Newly Diagnosed

Fluorescent Probe

Human Immunodeficiency Virus

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Rashmi Hullalli, M R Gudadinni, Rohith Motappa
A cross-sectional observational study to assess socio-demographic factors in newly diagnosed TB DM comorbidity. F1000Research 11 (2024)
Rashmi Hullalli, M R Gudadinni, Rohith Motappa
A cross-sectional observational study to assess socio-demographic factors in newly diagnosed TB DM comorbidity. F1000Research 11 (2024)
Pracheth Raghuveer, Ravjot Bhatia, Rohith Motappa, Malavika Sachith
A cross-sectional study on assessment of spiritual health and its associated factors among undergraduate students in a medical college in Mangalore, Karnataka. F1000Research 11 (2023)
Rashmi Hullalli, M R Gudadinni, Rohith Motappa
A cross-sectional observational study to assess socio-demographic factors in newly diagnosed TB DM comorbidity. F1000Research 11 (2022)
Rashmi Hullalli, M R Gudadinni, Rohith Motappa
A cross-sectional observational study to assess socio-demographic factors in newly diagnosed TB DM comorbidity. F1000Research 11 (2022)
Rohith Motappa, Tuba Fathima, Himani Kotian
Appraisal on patient compliance and factors influencing the daily regimen of anti-tubercular drugs in Mangalore city: A cross-sectional study. F1000Research 11 (2022)
Rohith Motappa, Tuba Fathima, Himani Kotian
Appraisal on patient compliance and factors influencing the daily regimen of anti-tubercular drugs in Mangalore city: A cross-sectional study. F1000Research 11 (2022)
Rashmi Hullalli, M R Gudadinni, Rohith Motappa
A cross-sectional observational study to assess socio-demographic factors in newly diagnosed TB DM comorbidity. F1000Research 11 (2022)
Rashmi Hullalli, M R Gudadinni, Rohith Motappa
A cross-sectional observational study to assess socio-demographic factors in newly diagnosed TB DM comorbidity. F1000Research 11 (2022)